Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 75

1.

Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial.

Hoffman RM, Angelidou KN, Brummel SS, Saidi F, Violari A, Dula D, Mave V, Fairlie L, Theron G, Kamateeka M, Chipato T, Chi BH, Stranix-Chibanda L, Nematadzira T, Moodley D, Bhattacharya D, Gupta A, Coletti A, McIntyre JA, Klingman KL, Chakhtoura N, Shapiro DE, Fowler MG, Currier JS; IMPAACT PROMISE 1077BF/FF team.

HIV Clin Trials. 2018 Dec;19(6):209-224. doi: 10.1080/15284336.2018.1537327.

PMID:
30890061
2.

Beyond Burnout: A Physician Wellness Hierarchy Designed to Prioritize Interventions at the Systems Level.

Shapiro DE, Duquette C, Abbott LM, Babineau T, Pearl A, Haidet P.

Am J Med. 2019 May;132(5):556-563. doi: 10.1016/j.amjmed.2018.11.028. Epub 2018 Dec 13. Review.

PMID:
30553832
3.

Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV.

Momper JD, Best BM, Wang J, Capparelli EV, Stek A, Barr E, Badell ML, Acosta EP, Purswani M, Smith E, Chakhtoura N, Park K, Burchett S, Shapiro DE, Mirochnick M; IMPAACT P1026s Protocol Team.

AIDS. 2018 Nov 13;32(17):2507-2516. doi: 10.1097/QAD.0000000000001992.

PMID:
30134297
4.

Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.

Rough K, Seage GR 3rd, Williams PL, Hernandez-Diaz S, Huo Y, Chadwick EG, Currier JS, Hoffman RM, Barr E, Shapiro DE, Patel K; PHACS and the IMPAACT P1025 Study Teams.

N Engl J Med. 2018 Apr 26;378(17):1593-1603. doi: 10.1056/NEJMoa1701666.

5.

Changing Patterns and Factors Associated With Mode of Delivery Among Pregnant Women With Human Immunodeficiency Virus Infection in the United States.

Venkatesh KK, Morrison L, Livingston EG, Stek A, Read JS, Shapiro DE, Tuomala RE.

Obstet Gynecol. 2018 May;131(5):879-890. doi: 10.1097/AOG.0000000000002566.

6.

Prevention of HIV-1 Transmission Through Breastfeeding: Efficacy and Safety of Maternal Antiretroviral Therapy Versus Infant Nevirapine Prophylaxis for Duration of Breastfeeding in HIV-1-Infected Women With High CD4 Cell Count (IMPAACT PROMISE): A Randomized, Open-Label, Clinical Trial.

Flynn PM, Taha TE, Cababasay M, Fowler MG, Mofenson LM, Owor M, Fiscus S, Stranix-Chibanda L, Coutsoudis A, Gnanashanmugam D, Chakhtoura N, McCarthy K, Mukuzunga C, Makanani B, Moodley D, Nematadzira T, Kusakara B, Patil S, Vhembo T, Bobat R, Mmbaga BT, Masenya M, Nyati M, Theron G, Mulenga H, Butler K, Shapiro DE; PROMISE Study Team.

J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):383-392. doi: 10.1097/QAI.0000000000001612.

7.

Time to first positive HIV-1 DNA PCR may differ with antiretroviral regimen in infants infected with non-B subtype HIV-1.

Balasubramanian R, Fowler MG, Dominguez K, Lockman S, Tookey PA, Huong NNG, Nesheim S, Hughes MD, Lallemant M, Tosswill J, Shaffer N, Sherman G, Palumbo P, Shapiro DE.

AIDS. 2017 Nov 28;31(18):2465-2474. doi: 10.1097/QAD.0000000000001640.

8.

Using a Simulation of a Frustrated Faculty Member During Department Chair Searches: A Proof of Concept Project.

Shapiro DE, Abbott LM, Wolpaw DR, Green MJ, Levi BH.

Acad Med. 2018 Feb;93(2):224-228. doi: 10.1097/ACM.0000000000001788.

PMID:
28640034
9.

Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention.

Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, McIntyre J, Gnanashanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM; IMPAACT 1077BF/1077FF PROMISE Study Team.

N Engl J Med. 2016 Nov 3;375(18):1726-1737.

10.

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women.

Tran AH, Best BM, Stek A, Wang J, Capparelli EV, Burchett SK, Kreitchmann R, Rungruengthanakit K, George K, Cressey TR, Chakhtoura N, Smith E, Shapiro DE, Mirochnick M; IMPAACT P1026s Protocol Team.

J Acquir Immune Defic Syndr. 2016 Jul 1;72(3):289-96. doi: 10.1097/QAI.0000000000000968.

11.

Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission.

Olson SC, Ngo-Giang-Huong N, Beck I, Deng W, Britto P, Shapiro DE, Bumgarner RE, Mullins JI, Van Dyke RB, Jourdain G, Frenkel LM.

AIDS. 2015 Jul 31;29(12):1467-71. doi: 10.1097/QAD.0000000000000737.

12.

Factors Associated With Lack of Viral Suppression at Delivery.

Katz IT, Shapiro DE, Tuomala R.

Ann Intern Med. 2015 Jun 16;162(12):874-5. doi: 10.7326/L15-5059-2. No abstract available.

13.

Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study.

Katz IT, Leister E, Kacanek D, Hughes MD, Bardeguez A, Livingston E, Stek A, Shapiro DE, Tuomala R.

Ann Intern Med. 2015 Jan 20;162(2):90-9. doi: 10.7326/M13-2005.

14.

Raltegravir pharmacokinetics during pregnancy.

Watts DH, Stek A, Best BM, Wang J, Capparelli EV, Cressey TR, Aweeka F, Lizak P, Kreitchmann R, Burchett SK, Shapiro DE, Hawkins E, Smith E, Mirochnick M; IMPAACT 1026s study team.

J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):375-81. doi: 10.1097/QAI.0000000000000318.

15.

Biomarkers from late pregnancy to 6 weeks postpartum in HIV-infected women who continue versus discontinue antiretroviral therapy after delivery.

Hoffman RM, Leister E, Kacanek D, Shapiro DE, Read JS, Bryson Y, Currier JS.

J Acquir Immune Defic Syndr. 2013 Aug 15;63(5):593-601. doi: 10.1097/QAI.0b013e31829b0b9f.

16.

Pharmacokinetics of an increased atazanavir dose with and without tenofovir during the third trimester of pregnancy.

Kreitchmann R, Best BM, Wang J, Stek A, Caparelli E, Watts DH, Smith E, Shapiro DE, Rossi S, Burchett SK, Hawkins E, Byroads M, Cressey TR, Mirochnick M.

J Acquir Immune Defic Syndr. 2013 May 1;63(1):59-66. doi: 10.1097/QAI.0b013e318289b4d2.

17.

Reduced indinavir exposure during pregnancy.

Cressey TR, Best BM, Achalapong J, Stek A, Wang J, Chotivanich N, Yuthavisuthi P, Suriyachai P, Prommas S, Shapiro DE, Watts DH, Smith E, Capparelli E, Kreitchmann R, Mirochnick M; IMPAACT P1026s team.

Br J Clin Pharmacol. 2013 Sep;76(3):475-83. doi: 10.1111/bcp.12078.

18.

Prevalence of HIV among women entering labor who accepted or declined voluntary counseling and testing.

Theron GB, Cababasay MP, Van Dyke RB, Shapiro DE, Louw J, Watts DH, Bulterys M, Styer LM, Maupin R.

Int J Gynaecol Obstet. 2013 Feb;120(2):141-3. doi: 10.1016/j.ijgo.2012.07.029. Epub 2012 Nov 9.

19.

Infant outcomes after maternal antiretroviral exposure in resource-limited settings.

Nielsen-Saines K, Komarow L, Cu-Uvin S, Jourdain G, Klingman KL, Shapiro DE, Mofenson L, Moran L, Campbell TB, Hitti J, Fiscus S, Currier J; ACTG 5190/PACTG 1054 Study Team.

Pediatrics. 2012 Jun;129(6):e1525-32. doi: 10.1542/peds.2011-2340. Epub 2012 May 14.

20.

Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel.

Cuevas LE, Browning R, Bossuyt P, Casenghi M, Cotton MF, Cruz AT, Dodd LE, Drobniewski F, Gale M, Graham SM, Grzemska M, Heinrich N, Hesseling AC, Huebner R, Jean-Philippe P, Kabra SK, Kampmann B, Lewinsohn D, Li M, Lienhardt C, Mandalakas AM, Marais BJ, Menzies HJ, Montepiedra G, Mwansambo C, Oberhelman R, Palumbo P, Russek-Cohen E, Shapiro DE, Smith B, Soto-Castellares G, Starke JR, Swaminathan S, Wingfield C, Worrell C.

J Infect Dis. 2012 May 15;205 Suppl 2:S209-15. doi: 10.1093/infdis/jir879. Epub 2012 Apr 3.

21.

A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.

Van Dyke RB, Ngo-Giang-Huong N, Shapiro DE, Frenkel L, Britto P, Roongpisuthipong A, Beck IA, Yuthavisuthi P, Prommas S, Puthanakit T, Achalapong J, Chotivanich N, Rasri W, Cressey TR, Maupin R, Mirochnick M, Jourdain G; IMPAACT P1032 Protocol Team.

Clin Infect Dis. 2012 Jan 15;54(2):285-93. doi: 10.1093/cid/cir798. Epub 2011 Dec 5.

22.

Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals.

Knapp KM, Brogly SB, Muenz DG, Spiegel HM, Conway DH, Scott GB, Talbot JT, Shapiro DE, Read JS.

Pediatr Infect Dis J. 2012 Feb;31(2):164-70. doi: 10.1097/INF.0b013e318235c7aa.

23.

Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants.

Flynn PM, Mirochnick M, Shapiro DE, Bardeguez A, Rodman J, Robbins B, Huang S, Fiscus SA, Van Rompay KK, Rooney JF, Kearney B, Mofenson LM, Watts DH, Jean-Philippe P, Heckman B, Thorpe E Jr, Cotter A, Purswani M; PACTG 394 Study Team.

Antimicrob Agents Chemother. 2011 Dec;55(12):5914-22. doi: 10.1128/AAC.00544-11. Epub 2011 Sep 6.

24.

Rapid intrapartum or postpartum HIV testing at a midwife obstetric unit and a district hospital in South Africa.

Theron GB, Shapiro DE, Van Dyke R, Cababasay MP, Louw J, Watts DH, Smith E, Bulterys M, Maupin R.

Int J Gynaecol Obstet. 2011 Apr;113(1):44-9. doi: 10.1016/j.ijgo.2010.10.011. Epub 2011 Jan 19.

25.

Prenatal protease inhibitor use and risk of preterm birth among HIV-infected women initiating antiretroviral drugs during pregnancy.

Patel K, Shapiro DE, Brogly SB, Livingston EG, Stek AM, Bardeguez AD, Tuomala RE; P1025 team of the International Maternal Pediatric Adolescent AIDS Clinical Trials Group.

J Infect Dis. 2010 Apr 1;201(7):1035-44. doi: 10.1086/651232.

26.

Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants.

Brogly SB, Foca M, Deville JG, Mirochnick M, Scott GB, Mofenson LM, Read JS, Viani RM, Burchett SK, Cooper ER, Browning R, Shapiro DE.

J Acquir Immune Defic Syndr. 2010 Jan;53(1):154-7. doi: 10.1097/QAI.0b013e3181b3adc2. No abstract available.

27.

Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals.

Ouyang DW, Brogly SB, Lu M, Shapiro DE, Hershow RC, French AL, Leighty RM, Thompson B, Tuomala RE.

AIDS. 2010 Jan 2;24(1):109-14. doi: 10.1097/QAD.0b013e3283323941.

28.

Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure.

Ouyang DW, Shapiro DE, Lu M, Brogly SB, French AL, Leighty RM, Thompson B, Tuomala RE, Hershow RC.

AIDS. 2009 Nov 27;23(18):2425-30. doi: 10.1097/QAD.0b013e32832e34b1.

29.

Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women.

Cressey TR, Van Dyke R, Jourdain G, Puthanakit T, Roongpisuthipong A, Achalapong J, Yuthavisuthi P, Prommas S, Chotivanich N, Maupin R, Smith E, Shapiro DE, Mirochnick M; IMPAACT P1032 Team.

Antimicrob Agents Chemother. 2009 May;53(5):2189-91. doi: 10.1128/AAC.01091-08. Epub 2009 Feb 23.

30.

Effects of teamwork training on adverse outcomes and process of care in labor and delivery: a randomized controlled trial.

Nielsen PE, Goldman MB, Mann S, Shapiro DE, Marcus RG, Pratt SD, Greenberg P, McNamee P, Salisbury M, Birnbach DJ, Gluck PA, Pearlman MD, King H, Tornberg DN, Sachs BP.

Obstet Gynecol. 2007 Jan;109(1):48-55.

PMID:
17197587
31.

Efficacy and safety of moxifloxacin as an additive in Optisol-GS a preservation medium for corneal donor tissue.

Ritterband DC, Shah MK, Meskin SW, Shapiro DE, Seedor JA, Koplin RS, Hu DN, Shao S, Dahl P, McCormick S.

Cornea. 2006 Oct;25(9):1084-9.

PMID:
17133059
32.

Evaluation of guided imagery as treatment for recurrent abdominal pain in children: a randomized controlled trial.

Weydert JA, Shapiro DE, Acra SA, Monheim CJ, Chambers AS, Ball TM.

BMC Pediatr. 2006 Nov 8;6:29.

33.

Laboratory model of tissue adhesive (2-octyl cyanoacrylate) in sealing clear corneal cataract wounds.

Ritterband DC, Meskin SW, Shapiro DE, Kusmierczyk J, Seedor JA, Koplin RS.

Am J Ophthalmol. 2005 Dec;140(6):1039-43.

PMID:
16376648
34.

Liquid bandage (2-octyl cyanoacrylate) as a temporary wound barrier in clear corneal cataract surgery.

Meskin SW, Ritterband DC, Shapiro DE, Kusmierczyk J, Schneider SS, Seedor JA, Koplin RS.

Ophthalmology. 2005 Nov;112(11):2015-21. Epub 2005 Sep 12.

PMID:
16157383
35.

Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332.

Wade NA, Unadkat JD, Huang S, Shapiro DE, Mathias A, Yasin S, Ciupak G, Watts DH, Delke I, Rathore M, Hitti J, Frenkel L, Samelson R, Smith ME, Mofenson L, Burchett SK.

J Infect Dis. 2004 Dec 15;190(12):2167-74. Epub 2004 Nov 10.

PMID:
15551216
36.

Assessing the learning needs of maternal and child health professionals to teach health promotion.

Bernstein HH, Rieber S, Stoltz RA, Shapiro DE, Connors KM.

Matern Child Health J. 2004 Jun;8(2):87-93.

PMID:
15198176
37.

Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis.

Ioannidis JP, Tatsioni A, Abrams EJ, Bulterys M, Coombs RW, Goedert JJ, Korber BT, Mayaux MJ, Mofenson LM, Moye J Jr, Newell ML, Shapiro DE, Teglas JP, Thompson B, Wiener J.

AIDS. 2004 Jan 2;18(1):99-108.

PMID:
15090835
38.

Rapid onset of cutaneous anesthesia with EMLA cream after pretreatment with a new ultrasound-emitting device.

Katz NP, Shapiro DE, Herrmann TE, Kost J, Custer LM.

Anesth Analg. 2004 Feb;98(2):371-6, table of contents.

PMID:
14742372
39.

A pilot study of the use of guided imagery for the treatment of recurrent abdominal pain in children.

Ball TM, Shapiro DE, Monheim CJ, Weydert JA.

Clin Pediatr (Phila). 2003 Jul-Aug;42(6):527-32.

PMID:
12921454
40.

Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival.

Bardeguez AD, Shapiro DE, Mofenson LM, Coombs R, Frenkel LM, Fowler MG, Huang S, Sperling RS, Cunningham B, Gandia J, Maupin R, Zorrilla CD, Jones T, O'Sullivan MJ; Pediatrics AIDS Clinical Trials Group 288 Protocol Team.

J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):170-81.

PMID:
12571527
41.

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, O'Sullivan MJ, Scott G, Stek AM, Wara D, Bulterys M.

N Engl J Med. 2002 Jun 13;346(24):1863-70.

42.

Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml.

Ioannidis JP, Abrams EJ, Ammann A, Bulterys M, Goedert JJ, Gray L, Korber BT, Mayaux MJ, Mofenson LM, Newell ML, Shapiro DE, Teglas JP, Wilfert CM.

J Infect Dis. 2001 Feb 15;183(4):539-45. Epub 2001 Jan 12.

PMID:
11170978
43.

Pervasive emotion recognition deficit common to alexithymia and the repressive coping style.

Lane RD, Sechrest L, Riedel R, Shapiro DE, Kaszniak AW.

Psychosom Med. 2000 Jul-Aug;62(4):492-501.

PMID:
10949094
44.

Stress management in medical education: a review of the literature.

Shapiro SL, Shapiro DE, Schwartz GE.

Acad Med. 2000 Jul;75(7):748-59. Review.

PMID:
10926029
45.

Exposure of the anterior spine: technique and experience with 66 patients.

Cohn EB, Ignatoff JM, Keeler TC, Shapiro DE, Blum MD.

J Urol. 2000 Aug;164(2):416-8.

PMID:
10893599
46.

Diagnostic tests: distinguishing good tests from bad and even ugly ones.

Farr BM, Shapiro DE.

Infect Control Hosp Epidemiol. 2000 Apr;21(4):278-84. Review.

PMID:
10782593
47.
48.

The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program.

Brambilla D, Reichelderfer PS, Bremer JW, Shapiro DE, Hershow RC, Katzenstein DA, Hammer SM, Jackson B, Collier AC, Sperling RS, Fowler MG, Coombs RW.

AIDS. 1999 Nov 12;13(16):2269-79.

PMID:
10563712
49.

A comparison of the bioavailabilities of oral and intravenous ethanol in healthy male volunteers.

Cobaugh DJ, Gibbs M, Shapiro DE, Krenzelok EP, Schneider SM.

Acad Emerg Med. 1999 Oct;6(10):984-8.

50.

The interpretation of diagnostic tests.

Shapiro DE.

Stat Methods Med Res. 1999 Jun;8(2):113-34. Review.

PMID:
10501649

Supplemental Content

Loading ...
Support Center